Literature DB >> 8110529

The epidemiology of vertebral fractures. European Vertebral Osteoporosis Study Group.

C Cooper1, T O'Neill, A Silman.   

Abstract

Vertebral fractures are recognised as a hallmark of osteoporosis, yet little is known of their epidemiology. This deficiency limits accurate characterisation of the public health importance of osteoporosis. Assessment of the impact of vertebral fractures has been hampered by the absence of formal criteria for identifying fractures on a thoracolumbar radiograph. Initial methods relying upon subjective radiological assessments have given way to morphometric measurements of vertebral heights, with deformities defined according to various algorithms. These methods have been used in a series of studies performed in Rochester, MN, to determine the incidence, outcome, and time trends of vertebral deformities. The results suggest a prevalence rate of vertebral deformity of 25.3 per 100 Rochester women aged 50 years and over (95% CI, 22.3-28.2), with an estimated incidence of 17.8 per 1,000 person-years. The incidence of clinically diagnosed vertebral fractures among women in the same population was 5.3 per 1,000 person-years, suggesting that around 30% of such deformities in women receive clinical attention. Morphometric measurement on the radiographs of women with clinically diagnosed fractures revealed that 80% had grade 2 ( > 4 SD) deformities. Comparable data on the occurrence and health impact of vertebral deformities throughout Europe are urgently required. The European Vertebral Osteoporosis Study (EVOS) is a multicentre epidemiological study that aims to address this issue. It is designed as a radiographic prevalence study in 34 European centres.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8110529     DOI: 10.1016/8756-3282(93)90358-h

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  73 in total

1.  Can self-reported height and weight be used to calculate 10 year risk of osteoporotic fracture?

Authors:  M J Bridges; S Ruddick
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

2.  Reviewer's comment concerning "Continuing conservative care versus cross-over to radiofrequency kyphoplasty: a comparative effectiveness study on the treatment of vertebral body fractures" (doi:10.1007/s00586-012-2148-8 by R. Bornemann, M. Hanna, K. Kabir, H. Goost, D. C. Wirtz, R. Pflugmacher).

Authors:  Luis Alvarez Galovich
Journal:  Eur Spine J       Date:  2012-03-13       Impact factor: 3.134

3.  Fractures in osteoporosis: the challenge for the new millennium.

Authors:  J Y Reginster; N Sarlet; M P Lecart
Journal:  Osteoporos Int       Date:  2005-01       Impact factor: 4.507

Review 4.  Treatment of low bone mass in premenopausal women: when may it be appropriate?

Authors:  Edward S Leib
Journal:  Curr Osteoporos Rep       Date:  2005-03       Impact factor: 5.096

5.  Vertebral morphometry reference data by X-ray absorptiometry (MXA) in Iranian women.

Authors:  A Salimzadeh; M Moghaddassi; G H Alishiri; M B Owlia; L Kohan
Journal:  Clin Rheumatol       Date:  2006-08-29       Impact factor: 2.980

6.  Epidemiology of osteoporosis in Taiwan.

Authors:  K S Tsai; T Y Tai
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

7.  Vertebral and metacarpal morphometry as indicators of nutritional improvement.

Authors:  M Revilla; E Fraile; F Aguado; E R Hermandez; L F Villa; H Rico
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

8.  The European Prospective Osteoporosis Study.

Authors:  J Reeve
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

9.  Sexual differences in bone markers and bone mineral density of normal Chinese.

Authors:  K S Tsai; W H Pan; S H Hsu; W C Cheng; C K Chen; P U Chieng; R S Yang; S T Twu
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

Review 10.  Exercise for improving outcomes after osteoporotic vertebral fracture.

Authors:  Lora M Giangregorio; Norma J Macintyre; Lehana Thabane; Carly J Skidmore; Alexandra Papaioannou
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.